Biohit HealthCare signs distribution contract with Euro Diagnostica

May 30, 2012 - Company News, Product News
Finnish healthcare company Biohit Plc. signed a distribution contract on Thursday May 24th with Euro Diagnostica, an international diagnostics company, based in Malmö, Sweden.

Euro Diagnostica will exclusively distribute and market Biohit’s biomarker test, GastroPanel, in Sweden, Norway and Denmark. The company singed also a non-exclusive distribution agreement for Germany, Switzerland and the Netherlands. GastroPanel examinations diagnose diseases of the stomach and the risks associated with these diseases.

‘’We are looking forward very much to the collaboration with Biohit as the company’s portfolio complements Euro Diagnostica’s line of business,’’ says Else Beth Trautner, the CEO of Euro Diagnostica.

Biohit’s CEO Semi Korpela is also pleased with the contract. ‘’I believe this is a perfect match and together we have all the chances to make this cooperation a very fruitful one’’.

Biohit HealthCare in brief

Biohit HealthCare is a globally operating biotechnology company that develops, manufactures and markets diagnostic tests and analysis systems.

Euro Diagnostica in brief

Euro Diagnostica is a full service diagnostic solutions company. During the last two decades, its world class scientists have been the first to develop and produce top quality ELISA kits for ANCA, anti-CCP, Complement and Chromogranin A assays which are now in use all over the world.

Additional information:

Please, visit this website for more information of the diagnostic tests.

Biohit Plc.

Semi Korpela, CEO

Tel: +358 9 773 86 333

Euro Diagnostica AB

Else Beth Trautner, CEO

Tel: +46 40 53 76 85

« Back